Kingsview Wealth Management, LLC Abb Vie Inc. Transaction History

Kingsview Wealth Management, LLC

$3.76 Billion
Q1 2024

A detailed history of Kingsview Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 62,644 shares of ABBV stock, worth $10.4 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

62,644

Previous 102,538 38.91%

Holding current value

$10.4 Million

Previous $15.9 Million 28.21%

% of portfolio

0.3%

Previous 0.48%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$159.82 - $182.1 $6.38 Million - $7.26 Million	-39,894 Reduced 38.91%	62,644 $11.4 Million
Q4 2023 Feb 08, 2024	SELL	$137.6 - $154.97 $289,097 - $325,591	-2,101 Reduced 2.01%	102,538 $15.9 Million
Q3 2023 Nov 07, 2023	BUY	$133.59 - $154.65 $3.75 Million - $4.34 Million	28,071 Added 36.66%	104,639 $15.6 Million
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $657,514 - $818,233	-4,962 Reduced 6.09%	76,568 $10.3 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $1 Million - $1.15 Million	-6,931 Reduced 7.84%	81,530 $13 Million

Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $799,846 - $959,226	-5,783 Reduced 6.14%	88,461 $14.3 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $359,951 - $412,840	-2,682 Reduced 2.77%	94,244 $12.6 Million
Q2 2022 Aug 16, 2022	BUY	$137.62 - $174.96 $2.53 Million - $3.22 Million	18,415 Added 23.46%	96,926 $14.8 Million
Q1 2022 Feb 08, 2024	SELL	$131.98 - $163.75 $2.71 Million - $3.36 Million	-20,510 Reduced 20.0%	82,028 $13.3 Million
Q4 2021 Feb 17, 2022	BUY	$107.43 - $135.93 $129,023 - $163,251	1,201 Added 1.55%	78,511 $10.6 Million
Q3 2021 Dec 03, 2021	BUY	$106.4 - $120.78 $1.08 Million - $1.23 Million	10,145 Added 15.1%	77,310 $8.34 Million
Q2 2021 Aug 17, 2021	BUY	$105.21 - $117.21 $1.89 Million - $2.1 Million	17,952 Added 36.48%	67,165 $7.67 Million
Q1 2021 May 24, 2021	BUY	$102.3 - $112.62 $579,018 - $637,429	5,660 Added 13.0%	49,213 $5.34 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $389,813 - $526,288	4,843 Added 12.51%	43,553 $4.67 Million
Q3 2020 Nov 19, 2020	BUY	$85.91 - $100.83 $546,645 - $641,581	6,363 Added 19.67%	38,710 $3.39 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $349,094 - $467,140	4,758 Added 17.25%	32,347 $3.18 Million
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $661,770 - $1 Million	10,260 Added 59.21%	27,589 $2.1 Million
Q4 2019 Jan 31, 2020	BUY	$72.13 - $90.25 $785,062 - $982,281	10,884 Added 168.88%	17,329 $1.53 Million
Q4 2019 Jan 30, 2020	SELL	$72.13 - $90.25 $262,697 - $328,690	-3,642 Reduced 36.11%	6,445 $623,000
Q3 2019 Jan 29, 2020	SELL	$62.98 - $75.72 $420,958 - $506,112	-6,684 Reduced 39.85%	10,087 $764,000
Q2 2019 Jan 29, 2020	SELL	$65.7 - $83.98 $166,023 - $212,217	-2,527 Reduced 13.09%	16,771 $1.22 Million
Q1 2019 Jan 29, 2020	SELL	$77.14 - $90.79 $1.88 Million - $2.21 Million	-24,342 Reduced 55.78%	19,298 $1.56 Million
Q4 2018 Jan 29, 2020	BUY	$77.85 - $96.01 $45,153 - $55,685	580 Added 1.35%	43,640 $4.02 Million
Q3 2018 Jan 29, 2020	BUY	$88.91 - $98.84 $77,173 - $85,793	868 Added 2.06%	43,060 $4.07 Million
Q2 2018 Jan 29, 2020	SELL	$89.78 - $106.23 $40,760 - $48,228	-454 Reduced 1.06%	42,192 $3.91 Million
Q1 2018 Jan 29, 2020	BUY	$92.01 - $123.21 $3.33 Million - $4.46 Million	36,201 Added 561.69%	42,646 $4.04 Million
Q4 2017 Jan 29, 2020	SELL	$89.56 - $98.21 $1,970 - $2,160	-22 Reduced 0.34%	6,445 $623,000
Q3 2017 Jan 29, 2020	BUY	$69.85 - $89.22 $156,533 - $199,942	2,241 Added 53.03%	6,467 $575,000
Q2 2017 Jan 29, 2020	BUY	N/A	581 Added 15.94%	4,226 $306,000
Q1 2017 Jan 29, 2020	BUY	N/A	3,645	3,645 $238,000

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.

Account

Kingsview Wealth Management, LLC Abb Vie Inc. Transaction History